Discussion
Extranodal non-Hodgkin's lymphoma (NHL) may involve organs such as the stomach, gastrointestinal tract, liver, pancreas, thyroid, nervous system, or skeletal system. However, primary penile lymphoma is an extremely rare variety of extranodal malignant NHL (1) . The most commonly affected site is the shaft, followed by the glans penis (1) . Diffuse penile swelling and nodular ulcers are the most common clinical presentations of this tumor. The patient in this report also presented with diffuse penile swelling. Difficulty in urination and priapism are uncommon clinical features. DLBCL of the penis is the most common histological variant (4), which was the diagnosis in this case.
Physical examination and radiological imaging investigation, including CT, magnetic resonance imaging (MRI) and PET, should be undertaken to stage the disease (5 Staging was performed using uorine-18-uorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) and revealed a FDG avid penile mass with enlarged and FDG avid multiple inguinal and aortocaval lymph nodes. A follow-up FDG PET-CT scan after eight cycles of combination chemotherapy showed complete remission of the disease. Thus, FDG PET-CT should be integrated in management protocols of rare primary penile lymphoma. ii • Diagnostic and Interventional Radiology hybrid imaging tool used for staging and response evaluation of various metabolically active tumors, including lymphoma. Because of the whole body nature of acquisition, FDG PET-CT can detect previously unknown sites of disease. Guo et al. (6) have previously reported the utility of FDG PET-CT in a case of primary penile lymphoma that presented as malignant priapism. Solav et al. (7) reported a case where penile FDG uptake was incidentally noted during PET-CT in a patient with pyrexia of unknown origin, which turned out to be lymphoma upon histopathological evaluation. In the present case, the baseline PET-CT detected disease in the penis as well as in inguinal and aortocaval nodes. It also ruled out the presence of disease in other sites.
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Multiple options, including surgical amputation, radiotherapy, and chemotherapy are available for the treatment of penile lymphoma (8) . However, because of the rarity of the condition, current guidelines are lacking. The present patient underwent R-CHOP chemotherapy (9) . It is known that FDG PET-CT is an excellent tool for monitoring treatment response after chemotherapy for lymphoma (10) . However, such data are lacking for penile lymphoma. In the present case, postchemotherapy FDG PET-CT was also performed, which showed complete remission. The patient was doing well at the 18th month follow-up.
The differential diagnosis for a penile mass includes both malignant and benign lesions. Malignant masses include squamous cell carcinoma of the penis, anterior urethral carcinoma, primary penile sarcoma (epithelioid sarcoma, Kaposi sarcoma, leiomyosarcoma, and rhabdomyosarcoma), penile lymphoma, and metastases to the penis. Benign masses include Cowper's duct syringocele, peri-urethral abscess, Peyronie's disease, partial thrombosis of the corpus cavernosum, penile hemangiomas, and penile root neurofibroma. The FDG PET-CT method has been shown to be particularly useful in differentiating malignant from benign lesions (11) . Masses that are FDG avid are usually malignant, which in the present case turned out to be malignant lymphoma. In addition, under physiological conditions, the diameter of lymph nodes in the inguinal region can exceed 1 cm in the absence of malignancy, which makes FDG PET-CT The present report highlights the utility of FDG PET-CT for staging and response monitoring of penile lymphoma. We are of the opinion that FDG PET-CT should be integrated in management protocols of primary penile lymphoma.
